Every year, Vietnam records more than 10,000 cases of leukemia.

(Dan Tri) - The number of hematological cancers accounts for about 5.8% of new cancer cases. The blood cancer group is estimated to cause about 7,331 deaths, accounting for 6.1% of total cancer deaths.

On August 9th, at a scientific conference on updating the diagnosis and treatment of some hematological diseases, Associate Professor Dr. Nguyen Tuan Tung, Deputy Director of Bach Mai Hospital, stated that the number of hematological disease cases is increasing rapidly globally.

In the US, for example, more than 60,000 new cases of malignant blood diseases such as acute myeloid leukemia, multiple myeloma, lymphoma, etc., are recorded each year; in Europe, the 5-year survival rate for acute myeloid leukemia is only about 25-30%.

In Vietnam, approximately over 10,000 cases of hematological cancer are recorded each year, accounting for 5.8% of all cancer cases.

According to Associate Professor Tung, hematological diseases, from benign to malignant, have diverse clinical manifestations that easily overlap with symptoms from many other specialties, making diagnosis and treatment complicated. Many cases are detected at a late stage, leading to difficulties in prognosis and long-term management.

Many hematological diseases such as multiple myeloma, lymphoma, myelofibrosis, etc., are also on the rise, especially in middle-aged and elderly people. Cutaneous lymphoma or other rare forms can develop silently for decades and are easily overlooked without in-depth specialist examination.

Experts say that many cases of hematological cancer are detected at a late stage, leading to difficulties in prognosis and long-term management (Photo: The Anh).

Speaking at the conference, Associate Professor Dr. Dao Xuan Co, Director of Bach Mai Hospital, said that the hospital is focusing its resources on implementing cell therapy, gene therapy, new generation targeted drugs, and expanding stem cell transplantation; while also developing genetic testing techniques, molecular biology, and applying AI and big data in the diagnosis and treatment of hematological diseases.

"New methods such as targeted therapy, immunotherapy, and hematopoietic stem cell transplantation have been implemented and yielded positive results. After more than 10 years, the hospital has successfully performed 142 transplants, helping many patients recover and have a chance to live longer. There is a case of leukemia that started treatment at the age of 21, and now the patient has a family and healthy children," Associate Professor Co informed.

Meanwhile, the cost of stem cell transplantation in Vietnam is much lower than abroad, only about 40-50 million VND after support from the Social Insurance Fund (whereas it can reach 2-6 billion VND overseas).

Globally , gene therapy has been approved by the US FDA for the treatment of several hematological disorders such as thalassemia, hemophilia, and some cancers.

Source: https://dantri.com.vn/suc-khoe/moi-nam-viet-nam-ghi-nhan-hon-10000-ca-ung-mau-20250809180903908.htm